We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sysmex Enters into R&D and Licensing Agreement with Merck Millipore

News   Mar 18, 2014

 
Sysmex Enters into R&D and Licensing Agreement with Merck Millipore
 
 
 

RELATED ARTICLES

Babies' Gut Bacteria Is Affected by Their Delivery Method

News

Babies born vaginally have different gut bacteria - their microbiome - than those delivered by Caesarean, research has shown.

READ MORE

New Study of HIV Vaccine Shows Promising Results Across Strains

News

Using the same RV 144 HIV vaccine employed in Thailand, a new study has evaluated whether the vaccine-induced immune responses to RV 144 are similar in a South African cohort.

READ MORE

Mutating Ebola Virus Protein Works as a Vaccine to Protect Animals From Infection

News

Creating mutations in a key Ebola virus protein that helps the deadly virus escape from the body's defenses can make the virus unable to produce sickness and activate protective immunity in the infected host, according to a study by the Institute for Biomedical Sciences at Georgia State University.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE